Eisai CNS Sales Force Will Promote Aricept, Zonegran
This article was originally published in The Pink Sheet Daily
Executive Summary
The central nervous sales force more than doubles the size of Eisai’s total sales team. The creation of a CNS sales force is part of a number of steps the Japanese company is taking to increase its presence in the U.S.
You may also be interested in...
Aventis Exec Moves To Eisai As VP-Sales
Former Aventis VP-Respiratory Franchise Head, Global Marketing & Medical Frank Ciriello is joining Eisai
Aventis Exec Moves To Eisai As VP-Sales
Former Aventis VP-Respiratory Franchise Head, Global Marketing & Medical Frank Ciriello is joining Eisai
Japanese Pharma Sea Change: U.S. Development Takes Focus Over Licensing
The traditional pattern of Japanese firms outlicensing their products for the West is shifting as the U.S. market looks increasingly appealing compared to Japan’s price controls and sagging economy. Major Japanese pharmas have been building U.S. development capability, resulting in a full pipeline of products to be developed and marketed directly in the U.S.